Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 21, 2011 OPK, Expected to Trade Lower After Bearish Insider Trading
June 21, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. OPKO HEALTH INCORPORATION (AMEX:OPK) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).
The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.
Symbol Company Name Insider Name Role Shares Insider Score Avg 6 Month Return # of Dec.
OPK OPKO HEALTH INCORPORATION Logal, Adam E OT 50,000 84 -54.6% 3
The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.
OPKO HEALTH INCORPORATION (AMEX:OPK) - OPKO Health, Inc., a specialty healthcare company, engages in the discovery, development, and commercialization of pharmaceutical products, medical devices, vaccines, diagnostic technologies, and imaging systems for treatment and management of ophthalmic diseases. Its product candidates include Rolapitant, which is in Phase III clinical trial to treat emesis; Bevasiranib that is in Phase III clinical trials for the treatment of wet age-related macular degeneration (Wet AMD); Doxovir, which is in Phase II clinical trials for viral conjunctivitis; SCH 900978 that is in Phase II clinical trials for emesis; and ACU-HHY-011 to treat wet AMD. The companys products under pre-clinical stage of development comprise Alzheimers test for Alzheimers diagnostic; flu vaccine for the treatment of pan-influenza; and OPK-HVB-004 and OPK-HVB-010 to treat wet AMD/diabetic retinopathy/diabetic macular edema. It also offers ophthalmic diagnostic systems and instrumentation products, including spectral OCT SLO combination imaging system and ultrasound products; and develops Aquashunt, a shunt used in the treatment of refractory open angle glaucoma. The company sells ophthalmic instruments, imaging products, and other medical devices to various eye care practitioners, including retinal and glaucoma specialists, ophthalmologists, optometrists, retail optometry chain outlets, teaching institutions, and military hospitals. It has strategic license agreements with the University of Texas, Southwestern Medical Center, Academia Sinica, the University of Pennsylvania, the University of Florida Research Foundation, and Redox Pharmaceuticals. The company was founded in 2006 and is headquartered in Miami, Florida.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net
- WOPRAI
- support@woprai.com
- www.woprai.com